100 μg of capsaicin was dissolved in 1 ml of liquid and was given in volumes of 1, 2, 3… 10 ml. |
Capsaicin was applied topically to the mucosa 5 cm in the gut by a plastic catheter via the stomal opening in patients with ileo- or colostomy. |
Capsaicin evoked pain and referred pain areas in all subjects. Moreover, sympathetic manifestations were quantified by significant increases in the blood flow and temperature of the referred area. |
Arendt-Nielsen et al. (2008) |
180 ml acid (HCL, 0.1 M) and 2 mg capsaicin in 20 ml of solvent (10 ml/min). |
Distal esophageal chemical perfusion (7 cm above lower esophageal sphincter). |
Rectal hyperalgesia to heat and mechanical stimulations were demonstrated after chemical perfusion of the esophagus. |
Brock et al. (2010) |
Increasing volumes of capsaicin 50 μg/ml (0.25–3 ml) |
Capsaicin was applied to the ileum via the stomal opening. |
Hyperalgesia was found to cause distension of the gut after capsaicin application. |
Drewes et al. (2003) |
2.5 ml Tabasco capsaicin-containing red pepper sauce suspension. |
Intraesophageal application of a capsaicin solution (10 cm above the lower esophageal sphincter). |
Decreased perception and discomfort threshold of intraesophageal balloon distension. |
Gonzalez et al. (1998) |
180 ml of acid (HCL, 0.1 M) and 2 mg of capsaicin in 20 ml of solvent (10 ml/min). |
Intraesophageal perfusion (7 cm above lower esophageal sphincter). |
Results from evoked brain potentials following painful electrical stimulation of the rectosigmoid colon demonstrated visceral hypersensitivity as increased EEG power in the delta, theta, and alpha frequency bands were found. |
Graversen et al. (2011) |
Capsaicin (200 μg/ml, 2.5 ml/min). Duration of perfusion was 60 min or until discomfort. |
Intraluminal capsaicin in different regions of the upper gastrointestinal tract. |
In the duodenum, barostat volumes at sensation and discomfort were comparable before and after capsaicin perfusion, whereas in the jejunum balloon volumes were lower after capsaicin infusion. |
Hammer and Vogelsang (2007) |
Pretreatment: capsules (0.5 mg capsaicin) three times per day for 7 days. |
Before and after capsule ingestion, the jejunum was distended with a balloon and perfused with a capsaicin solution. |
Distension with 40 ml induced lower perception scores after 1 week of capsaicin treatment (desensitization). During capsaicin perfusion, discomfort thresholds were reported earlier after 1 week of capsaicin treatment (sensitization). |
Hammer (2006) |
Capsaicin perfusion: 40 μg/ml (infusion rate of 2.5 ml/min). Duration of perfusion was 60 min or until discomfort. |
|
|
|
3 ml of a 0.17 mg/ml capsaicin solution, diluted with saline to a total volume of 10 ml |
Intraesophageal capsaicin installation |
No differences in symptom pattern or intensities induced by esophageal acid perfusion were found and neither was sensitivity to esophageal balloon distention. |
Kindt et al. (2009) |
0.84 mg capsaicin in 5 ml Tabasco capsaicin-containing red pepper sauce (10 ml/min.) |
Capsaicin was applied in the gastric fundus. |
After capsaicin perfusion, higher perception scores were reached for the same distending pressures by gastric barostat. |
Lee et al. (2004) |
180 ml of acid (HCL, 0.1 M) and 2 mg capsaicin in 20 ml of solvent (10 ml/min). |
Distal esophageal chemical perfusion (7 cm above lower esophageal sphincter). |
Reduction of the pain threshold to esophageal heat and electrical stimuli. Increase of the referred pain areas to esophageal mechanical and electrical stimulation. |
Olesen et al. (2009) |
Capsaicin solutions (40, 200, and 400 μg /ml) 2.5 ml/min were perfused for 60 min or until severe discomfort occurred. |
Perfusion site at the ligament of Treitz and, 7 cm distally, a barostat balloon. |
Repeated capsaicin (200 μg/ml) applications reduced time until discomfort occurred. Pain thresholds during distensions were not different before and after capsaicin perfusion. |
Schmidt et al. (2004) |